Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Doi

Showing results (451-460 of 494) with videos related to

Pageof 50
Sort By:
Microbial Genomics|July 7, 2026
Genomic analysis of intrahospital transmission of carbapenem-resistant Gram-negative bacteria: a multicentre study in JapanYasufumi Matsumura, Yohei Doi, Kayoko Hayakawa, et al.
Japanese Journal of Radiology|June 25, 2022
Response to RMED-D-22-00,258.R1Yoshiharu Ohno, Kota Aoyagi, Kazumasa Arakita, et al.
Microbiology Spectrum|April 27, 2026
Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in JapanKoji Ohyama, Kohei Uemura, Yasufumi Matsumura, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 22, 2021
Molecular characterization of clinical carbapenem-resistant Enterobacterales from QatarFatma Ben Abid, Clement K M Tsui, Yohei Doi, et al.
Japanese Journal of Radiology|April 9, 2022
Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effectYoshiharu Ohno, Kota Aoyagi, Kazumasa Arakita, et al.
Open Forum Infectious Diseases|October 17, 2025
Features of Carbapenem-resistant Gram-negative Bacterial Infections in Japan Based on the Setting of OnsetYuya Kawamoto, Yusuke Asai, Aki Sakurai, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2024
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolatesKevin J Westbrook, Gayatri Shankar Chilambi, Madison E Stellfox, et al.
The Lancet. Infectious Diseases|February 1, 2017
Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical studyYang Wang, Guo-Bao Tian, Rong Zhang, et al.
JCI Insight|September 29, 2022
A heterozygous LAMA5 variant may contribute to slowly progressive, vinculin-enhanced familial FSGS and pulmonary defectsJun-Ya Kaimori, Yamato Kikkawa, Daisuke Motooka, et al.
Vaccines|December 23, 2023
A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2Takenao Koseki, Mayumi Teramachi, Minako Koga, et al.
Pageof 50

Showing results (451-460 of 494) with videos related to

Sort By:
Pageof 50
Microbial Genomics|July 7, 2026
Genomic analysis of intrahospital transmission of carbapenem-resistant Gram-negative bacteria: a multicentre study in JapanYasufumi Matsumura, Yohei Doi, Kayoko Hayakawa, et al.
Japanese Journal of Radiology|June 25, 2022
Response to RMED-D-22-00,258.R1Yoshiharu Ohno, Kota Aoyagi, Kazumasa Arakita, et al.
Microbiology Spectrum|April 27, 2026
Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in JapanKoji Ohyama, Kohei Uemura, Yasufumi Matsumura, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 22, 2021
Molecular characterization of clinical carbapenem-resistant Enterobacterales from QatarFatma Ben Abid, Clement K M Tsui, Yohei Doi, et al.
Japanese Journal of Radiology|April 9, 2022
Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effectYoshiharu Ohno, Kota Aoyagi, Kazumasa Arakita, et al.
Open Forum Infectious Diseases|October 17, 2025
Features of Carbapenem-resistant Gram-negative Bacterial Infections in Japan Based on the Setting of OnsetYuya Kawamoto, Yusuke Asai, Aki Sakurai, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2024
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolatesKevin J Westbrook, Gayatri Shankar Chilambi, Madison E Stellfox, et al.
The Lancet. Infectious Diseases|February 1, 2017
Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical studyYang Wang, Guo-Bao Tian, Rong Zhang, et al.
JCI Insight|September 29, 2022
A heterozygous LAMA5 variant may contribute to slowly progressive, vinculin-enhanced familial FSGS and pulmonary defectsJun-Ya Kaimori, Yamato Kikkawa, Daisuke Motooka, et al.
Vaccines|December 23, 2023
A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2Takenao Koseki, Mayumi Teramachi, Minako Koga, et al.
Pageof 50